Dose-dense weekly docetaxel and CBDCA in adriamycin-resistant metastatic breast cancer (MBC)

被引：5
|
作者：
Salimi, M [1 ]
Mir, MR [1 ]
机构：
[1] Mehr Hosp, Iranian Canc Inst, Tehran, Iran
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80167-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [31] Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen
    Tomasello, Gianluca
    Dalla Chiesa, Matteo
    Buti, Sebastiano
    Brighenti, Matteo
    Negri, Federica
    Rovere, Rodrigo Kraft
    Martinotti, Mario
    Buononato, Massimo
    Brunelli, Antonio
    Lazzarelli, Silvia
    Donati, Gianvito
    Passalacqua, Rodolfo
    TUMORI, 2010, 96 (01) : 48 - 53
  • [32] Gemcitabine and docetaxel combination regimen in metastatic breast cancer (MBC)
    Karacetin, D.
    Maral, O.
    Aksakal, O.
    Okten, B.
    Yalcin, B.
    Incekara, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Altered expression of integrins in adriamycin-resistant human breast cancer cells
    Narita, T
    Kimura, N
    Sato, M
    Matsuura, N
    Kannagi, R
    ANTICANCER RESEARCH, 1998, 18 (1A) : 257 - 262
  • [34] Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer
    Stemmler, HJ
    Gutschow, K
    Sommer, H
    Malekmohammadi, M
    Kentenich, C
    Forstpointner, R
    Geuenich, S
    Bischoff, J
    Hiddemann, W
    Heinemann, V
    ANNALS OF ONCOLOGY, 2001, 12 (10) : 1393 - 1398
  • [35] Weekly docetaxel in the treatment of patients with metastatic breast cancer
    Grecea, Daniela
    Vasiliniuc, Carmen
    Ghilezan, Nicolae
    ANNALS OF ONCOLOGY, 2004, 15 : 53 - 53
  • [36] Docetaxel administered on a weekly basis for metastatic breast cancer
    Burstein, HJ
    Manola, J
    Younger, J
    Parker, LM
    Bunnell, CA
    Scheib, R
    Matulonis, UA
    Garber, JE
    Clarke, KD
    Shulman, LN
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1212 - 1219
  • [37] Protracted administration of weekly docetaxel in metastatic breast cancer
    Kuroi, K
    Bando, H
    Saji, S
    Toi, M
    ONCOLOGY REPORTS, 2003, 10 (05) : 1479 - 1484
  • [38] Adjuvant dose-dense adriamycin plus cytoxan followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: A pilot study
    Pippen, J.
    O'Shaughnessy, J.
    Ambro, S.
    Krekow, L.
    Stokoe, C.
    Bhar, P.
    Iglesias, J.
    Robert, N.
    BREAST, 2009, 18 : S57 - S57
  • [39] Current status of dose-dense chemotherapy for breast cancer
    Andrew D. Seidman
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 78 - 83
  • [40] Dose-dense neoadjuvant chemotherapy in breast cancer.
    Catane, R
    Kaufman, B
    Zach, L
    Wolf, I
    Gluck, I
    Modiano, T
    Barsuk, D
    Shabtai, M
    Papa, M
    Paluch-Shimon, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 79S - 79S
12345